Stocks/PRME

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

PRME

ACCE Researched
Prime Medicine Inc. Common Stock
HealthcareBiotechnologyNASDAQ
$3.41
-3.81%today
MKT CAP
$616M
NEXT EARNINGS
Mar 3

Analysis in progress.

+117.2% · 1Y
5
Total
73
Growth
58
Value
82
Quality
61
Momentum
Score breakdown on Starter+
Upgrade →
Score History (90d)
Pro onlyUpgrade →
Updated 5/3/2026
Get the ACCE weekly digest
Index returns, picks recap, score movers — every Sunday. No fluff.